IL1B and obesity disorder: Increased IL-1β levels are attributed to NF-κB activation and NOD-like receptor family, pyrin domain containing 3 (NLRP3) activity, which in turn could be stimulated in obesity by several factor such as FA, cholesterol, ROS and hyperglycemia (146).